- ►diabetesjournals.org JA Johnson, SR Majumdar, SH Simpson, EL … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Saskatchewan Health databases were used to examine
population-based mortality rates for new users of oral antidiabetic agents.
Individuals with prescriptions for sulfonylurea or metformin in 1991–1996 ... Cited by 152 - Related articles - BL Direct - All 7 versions
J Olsson, G Lindberg, M Gottsäter, K Lindwall, … - Diabetologia, 2000 - Springer Both sulphonylureas (SU) and metformin (MET) re- duce hyperglycaemia in patients
with Type II (non-in- sulin-dependent) diabetes mellitus, but they do so by ...
Increased mortality in Type II diabetic patients Cited by 89 - Related articles - BL Direct - All 3 versions
EZ Fisman, A Tenenbaum, V Boyko, M Benderly … - Clinical cardiology, 2001 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 54 - Related articles - BL Direct - All 6 versions
JMM Evans, SA Ogston, A Emslie-Smith, AD … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis: The aim of this study was to evaluate the risk of
adverse cardiovascular outcomes in patients with type 2 diabetes newly treated
with sulfo- nylureas and metformin. Subjects and methods: The Diabetes ... Cited by 53 - Related articles - BL Direct - All 3 versions
- Free from Publisher A Sasali, JL Leahy - Diabetes Care, 2003 - Am Diabetes Assoc The study by Johnson et al. (1) in the December 2002 issue of Diabetes Care
makes conclusions that in part seem to support the controversial finding of the
UK Prospective Diabetes Study (UKPDS) that metformin usage as monotherapy ... Cited by 16 - Related articles - BL Direct - All 5 versions
JA Johnson, SH Simpson, EL Toth, SR … - Diabetic Medicine, 2005 - interscience.wiley.com Methods We conducted a retrospective cohort analysis, using Saskatchewan Health
administrative databases to identify new users of oral antidiabetic drugs.
Subject groups were defined by medication use during 1991–1999: ... Cited by 40 - Related articles - All 6 versions
PJ Grant - Diabetes Care, 1996 - Am Diabetes Assoc OBJECTIVE: To study the dose response to metformin in type II diabetic patients.
RESEARCH DESIGN AND METHODS: Type II diabetic patients with a BMI > 25 were
treated with 3,000 mg/day (n = 27), 1,500 mg/day (n = 25), or placebo (n = ... Cited by 111 - Related articles - BL Direct - All 5 versions
P Vague - Diabetes & metabolism, 2003 - ncbi.nlm.nih.gov 1: Diabetes Metab. 2003 Sep;29(4 Pt 2):6S5-7. Is metformin more than an oral
hypoglycaemic agent? Vague P. Publication Types: Editorial; ... Cited by 13 - Related articles - BL Direct
[CITATION] Health databases in Saskatchewan
W Downey, P Beck, M McNutt, MR Stang, W … - Pharmacoepidemiology. Chichester: Wiley, 2000 Cited by 80 - Related articles
JG Jollis, RJ Simpson… - American Heart Journal, 1999 - Elsevier Randomized trial and experimental data suggest that sulfonylurea agents may be
associated with increased cardiovascular mortality rates. The University Group
Diabetes Program (UGDP), a randomized trial of diabetes therapy, concluded ... Cited by 40 - Related articles - BL Direct - All 7 versions
